26 Facts About Harvey Lodish

Harvey Franklin Lodish was born on November 16,1941 and is a molecular and cell biologist, professor at the Massachusetts Institute of Technology, Founding Member of the Whitehead Institute for Biomedical Research, and lead author of the textbook Molecular Cell Biology.

Harvey Lodish was promoted to Professor in 1976, and in 1983 was appointed Founding Member of the new Whitehead Institute for Biomedical Research by Founding Director David Baltimore.

In 1999, Dr Harvey Lodish became Professor of Biological Engineering in the new MIT Department of Biological Engineering.

Dr Harvey Lodish has served on advisory panels for the US National Institutes of Health and National Science Foundation and the American Cancer Society.

Harvey Lodish was Chair of the advisory board of the Division of Basic Sciences of the Fred Hutchinson Cancer Center and of the Lerner Research Institute of the Cleveland Clinic.

Harvey Lodish has served on the advisory boards of several other institutions, including the Biozentrum of the University of Basel, the European Molecular Biology Laboratory in Heidelberg, the Center for Molecular Biology Heidelberg in Germany, the Life Sciences Institute of the University of Michigan, and the PEW Scholars Program in Biomedical Sciences.

Harvey Lodish has served on the Visiting Committees of the California Institute of Technology Division of Biology and of the Engineering Division of the University of California Santa Barbara.

Harvey Lodish is currently on the Advisory Boards of the Chinese Organization for Rare Disorders and the Lausanne RE Discovery Institute for rare diseases.

From 1989 through 2007 Dr Harvey Lodish was a member of the Board of Trustees of Kenyon College, and currently is an Emeritus Trustee.

Dr Harvey Lodish is a member of the Board of Trustees of Boston Children's Hospital, where he was Chair of the Research Committee of the Board of Trustees.

Dr Harvey Lodish is the lead author of the textbook Molecular Cell Biology.

Dr Harvey Lodish was a founder and scientific advisory board member of Genzyme, Inc.

Harvey Lodish has served on the Scientific Advisory Board for the Eisai Research Institute in Massachusetts and on the Scientific Advisory Board of Astra and then AstraZeneca Pharmaceuticals.

Harvey Lodish has testified as an expert witness in several high- profile biotechnology patent trials in Federal Court, notably Amgen vs TKT Aventis in 2000, Amgen vs Roche in 2009, and Biogen vs Merck - Serono in 2018; he was on the winning side in all.

Harvey Lodish defined the biosynthesis and maturation of the vesicular stomatitis virus and other plasma membrane glycoproteins, identified the intracellular organelles that mediate recycling of the asialoglycoprotein and transferrin receptors, and clarified the role of pH changes in delivery of iron to cells and recycling of the transferrin receptor.

Harvey Lodish's group has elucidated steps in folding and oligomerization of several proteins within the endoplasmic reticulum, showed that exit of newly made proteins from this organelle requires that they be properly folded, and developed probes for measurement of the redox state within the endoplasmic reticulum.

Harvey Lodish closed his laboratory in 2019; the most recent efforts of his group were focused on:.

Harvey Lodish has taught undergraduate courses at MIT in Molecular Biology, Cell Biology, and most recently Molecular Biotechnology.

Dr Harvey Lodish is a Member of the National Academy of Sciences, and served as Chair of the National Academy Section on Cellular and Developmental Biology.

Harvey Lodish is a Fellow of the American Association for the Advancement of Science, a Fellow of the American Academy of Arts and Sciences, a Fellow of the American Academy of Microbiology, an Associate Member of the European Molecular Biology Organization, and a Foreign Member of the Royal Academy of Medicine of Belgium.

Dr Harvey Lodish received a MERIT award from the National Institute of Diabetes and Digestive and Kidney Diseases.

Harvey Lodish is a recipient of a Guggenheim Fellowship, the Stadie Award from the American Diabetes Association, and the 2010 Mentoring Award from the American Society of Hematology.

Harvey Lodish received the 2016 Pioneer Award from the Diamond Blackfan Anemia Foundation, and the Metcalf Lifetime Achievement Award from the International Society for Experimental Hematology in 2020.

Harvey Lodish is the recipient of honorary Doctorate of Science degrees from Kenyon College, the Chinese University of Hong Kong, and Case Western Reserve University.

Two former postdoctoral researchers in Dr Harvey Lodish's laboratory have gone on to win Nobel Prizes: Aaron Ciechanover and James Rothman.

In 1982 Dr Harvey Lodish was elected to the Cleveland Heights High School Alumni Hall of Fame, an honor he shares with his two younger brothers Leonard and Richard.